Understanding AMH Levels in Healthy Females Ages 0-18
This study aims to better understand normal levels of Anti-mullerian Hormone (AMH) in healthy females from birth to 18 years old. AMH is a chemical in the blood that can help estimate a female's ability to have children. While AMH levels are well understood in adults, more information is needed for children and adolescents. By collecting blood samples during routine outpatient surgeries, researchers hope to learn how AMH levels relate to a female's reproductive development. This knowledge could help doctors better assess the risk of infertility in young cancer patients and explore options to preserve their ability to have children in the future. The study plans to enroll 100 participants.
- Study design
- This interventional study plans to enroll 100 healthy females. It is not specified if it is randomized or blinded.
- What's involved
- If you participate, a blood sample will be collected during a routine outpatient surgical procedure you are already undergoing.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your Anti-mullerian Hormone Levels will be measured at 3 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Anti-mullerian Hormone Levels in Healthy Females
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Erin Rowell, MD · PRINCIPAL_INVESTIGATOR · Ann & Robert H Lurie Children's Hospital of Chicago
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Anti-mullerian Hormone Levels in Healthy Females3 Years
The primary outcome measure is to get a better understanding of the normal AMH levels in children (girls aged 0-18 years) in order to better assess a girl's risk of not being able to have children if she is a cancer patient, and in offering her and her family options to increase the chances of having her own children